[1]
P. Valera, P. Letuka, N. Mathenjwa, and N. Ntusi, “Angiotensin converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists and SARS-CoV-2 infection”, SAHJ, vol. 17, no. 3, pp. 352–361, Nov. 2020.